GLPA (HR: 2.67; 95% CI, 1.00-7.12; P = .050) and alpha-glucosidase inhibitor (HR: 1.76; 95% CI, 1.16-2.65; P = .008) were associated with PaC both in univariable and multivariable analyses adjusting for DM duration, mean HbA1c, and pancreatic diseases. Here, GAA is linked to pancreas disorder.